Kee Hung Chu

Nessuna posizione attualmente

78 anni

Consumer Services

Distribution Services

Health Technology

Profilo

Kee Hung Chu served as an Executive Director, Chief Scientific Officer & VP at CK Life Sciences International (Holdings), Inc. from 2001 to 2018.
Prior to that, he was a Director at WEX Pharmaceuticals, Inc. from 2009 to 2011.
Chu holds a graduate degree and a doctorate from the University of California, Berkeley, and an undergraduate degree from The Chinese University of Hong Kong.

Precedenti posizioni note di Kee Hung Chu

Società	Posizione	Fine
WEX Pharmaceuticals, Inc. WEX Pharmaceuticals, Inc. Medical DistributorsDistribution Services WEX Pharmaceuticals, Inc. develops, manufactures, and sells pharmaceutical products for pain management. The pain management solutions are provided through its proprietary platform technology based on TTX (Tetrodotoxin). It owns and operates its research, development and manufacturing facilities in China through its subsidiaries. The company was founded on June 3, 1987 and is headquartered in Vancouver, Canada.	Direttore/Membro del Consiglio	01/05/2011
CK LIFE SCIENCES INT'L., (HOLDINGS) INC.	Direttore Tecnico/Scientifico/R&S	15/11/2018

Vedi nel dettaglio l'esperienza di Kee Hung Chu

Formazione di Kee Hung Chu

The Chinese University of Hong Kong	Undergraduate Degree
University of California, Berkeley	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Kee Hung Chu

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
CK LIFE SCIENCES INT'L., (HOLDINGS) INC.	Health Technology

Aziende private	1
WEX Pharmaceuticals, Inc. WEX Pharmaceuticals, Inc. Medical DistributorsDistribution Services WEX Pharmaceuticals, Inc. develops, manufactures, and sells pharmaceutical products for pain management. The pain management solutions are provided through its proprietary platform technology based on TTX (Tetrodotoxin). It owns and operates its research, development and manufacturing facilities in China through its subsidiaries. The company was founded on June 3, 1987 and is headquartered in Vancouver, Canada.	Distribution Services